Haba Laboratories
4925.TChemicals
Filed as HABA LABORATORIES,INC. (2022-06–2026-06)
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥12.1bn | ¥12.1bn | ¥12.3bn | ¥12.0bn | ¥12.9bn | ¥14.3bn |
| Operating income | ¥727m | ¥590m | −¥188m | −¥610m | −¥317m | ¥227m |
| Ordinary income | ¥708m | ¥609m | −¥191m | −¥583m | −¥293m | ¥251m |
| Net income (owners) | ¥760m | ¥577m | −¥2.1bn | −¥708m | −¥269m | ¥216m |
| Total assets | ¥12.5bn | ¥12.3bn | ¥12.4bn | ¥14.7bn | ¥15.7bn | ¥17.4bn |
| Net assets / equity | ¥9.5bn | ¥8.9bn | ¥8.5bn | ¥10.8bn | ¥11.6bn | ¥12.0bn |
| Operating cash flow | ¥1.2bn | ¥1.6bn | −¥588m | ¥56m | ¥1.7bn | ¥535m |
| EPS (basic) | ¥201.07 | ¥152.47 | ¥-560.26 | ¥-187.19 | ¥-71.14 | ¥57.23 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 13
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2026-03-31 | Annual | 196 figures · EDINET |
| 2025-04-01 → 2025-09-30 | Half-year | 67 figures · EDINET |
| 2024-04-01 → 2025-03-31 | Annual | 196 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 67 figures · EDINET |
| 2023-04-01 → 2024-03-31 | Annual | 196 figures · EDINET |
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 45 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 69 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 43 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 196 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 45 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 69 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 43 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 196 figures · EDINET |
21 more reports are still being processed.